InvestorsHub Logo
Followers 9
Posts 540
Boards Moderated 0
Alias Born 01/26/2014

Re: None

Tuesday, 04/01/2014 11:13:45 AM

Tuesday, April 01, 2014 11:13:45 AM

Post# of 3836
I have a wee bit of science background, just enough to be familiar with the scientific process and some of the pathway stuff and I, personally, am quite impressed with the results. I see nothing but positive from this release. I was wondering, when people were talking about skipping ahead in trials, just how that would work. The effective dosages MUST be determined and that can only happen through the appropriate phases of the trial. And, as Dr. Traber mentioned, Phase two design is largely dependent on the results of Phase 1.

I hope the price stays down a bit longer so I can accumulate more. I at least have the feeling that I may be able to pick up some on the dips in the next few months and that makes me quite happy. Sadly, it'll be in little bits and pieces, I have no capital today...Looking at the application for options trading on Scottrade, I doubt that I'll qualify to be able to trade options. I may apply anyway. I think adding a few Oct. calls now might be a good strategy for me (as well as sucking up warrants when they fall to the appropriate level proportionate to the share price).

Has there been any mention of when melanoma study results may be available? That'll be interesting!

Thanks again all.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GALT News